NT-proBNP

Advertisement
Mark Belkin, MDACC 2021 Conference | April 19, 2023
Editor's Note: This dispatch from ACC.21 was written by Mark Belkin, MD, a cardiology fellow at the University of ...
Read More
DocWire News EditorsAHA Scientific Sessions 2018 | April 11, 2023
Empagliflozin, an SGLT2 inhibitor, significantly reversed left ventricular (LV) remodeling in a population of diabetic ...
DocWire News EditorsAtrial Fibrillation | April 7, 2023
Biomarkers were useful in predicting specific causes of death in patients with atrial fibrillation ...
DocWire News EditorsACC 2018 Conference | April 3, 2023
The beta-blocker carvedilol showed some benefit for protecting against heart injury resulting from chemotherapy-induced ...
Advertisement
Advertisement
Advertisement
Latest News

March 14, 2025